Shopping Cart
Remove All
Your shopping cart is currently empty
Clazakizumab is a humanized monoclonal antibody targeting human interleukin -6(IL-6) with high affinity. By directly binding IL-6 ligand, it blocks its interaction with IL-6 receptor (IL-6α) and signal co-receptor gp130, thus inhibiting the activation of downstream JAK/STAT signaling pathway and weakening the inflammatory response. Clazakizumab can be used in the study of psoriasis arthritis and antibody-mediated organ transplant rejection.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $415 | - | In Stock | |
| 5 mg | $1,250 | - | In Stock | |
| 10 mg | $1,990 | - | In Stock |
| Description | Clazakizumab is a humanized monoclonal antibody targeting human interleukin -6(IL-6) with high affinity. By directly binding IL-6 ligand, it blocks its interaction with IL-6 receptor (IL-6α) and signal co-receptor gp130, thus inhibiting the activation of downstream JAK/STAT signaling pathway and weakening the inflammatory response. Clazakizumab can be used in the study of psoriasis arthritis and antibody-mediated organ transplant rejection. |
| Targets&IC50 | IL-6:< 10 pM(Kd) |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | IL-6 |
| Cas No. | 1236278-28-6 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.